Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic index.

Schultz NA, Andersen KK, Roslind A, Willenbrock H, Wøjdemann M, Johansen JS.

World J Surg. 2012 Nov;36(11):2699-707. doi: 10.1007/s00268-012-1705-y.

PMID:
22851141
2.

High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer.

Giovannetti E, van der Velde A, Funel N, Vasile E, Perrone V, Leon LG, De Lio N, Avan A, Caponi S, Pollina LE, Gallá V, Sudo H, Falcone A, Campani D, Boggi U, Peters GJ.

PLoS One. 2012;7(11):e49145. doi: 10.1371/journal.pone.0049145. Epub 2012 Nov 14.

3.

Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.

Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, Zhao HW, Chen W, He YL, Wang HY, Xie D, Luo JH.

Lancet Oncol. 2013 Dec;14(13):1295-306. doi: 10.1016/S1470-2045(13)70491-1. Epub 2013 Nov 13. Erratum in: Lancet Oncol. 2014 Jan;15(1):e4.

PMID:
24239208
4.

MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer.

Ohuchida K, Mizumoto K, Kayashima T, Fujita H, Moriyama T, Ohtsuka T, Ueda J, Nagai E, Hashizume M, Tanaka M.

Ann Surg Oncol. 2011 Aug;18(8):2381-7. doi: 10.1245/s10434-011-1602-x. Epub 2011 Feb 23.

5.

The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer.

Takahashi M, Cuatrecasas M, Balaguer F, Hur K, Toiyama Y, Castells A, Boland CR, Goel A.

PLoS One. 2012;7(10):e46684. doi: 10.1371/journal.pone.0046684. Epub 2012 Oct 3.

6.

MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.

Nakata K, Ohuchida K, Mizumoto K, Kayashima T, Ikenaga N, Sakai H, Lin C, Fujita H, Otsuka T, Aishima S, Nagai E, Oda Y, Tanaka M.

Surgery. 2011 Nov;150(5):916-22. doi: 10.1016/j.surg.2011.06.017.

PMID:
22018284
7.

Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.

Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R.

Oncol Rep. 2012 Jun;27(6):1759-64. doi: 10.3892/or.2012.1709. Epub 2012 Mar 7.

PMID:
22407237
8.

MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.

Yu J, Ohuchida K, Mizumoto K, Fujita H, Nakata K, Tanaka M.

Cancer Biol Ther. 2010 Oct 15;10(8):748-57. doi: 10.4161/cbt.10.8.13083. Epub 2010 Oct 15.

PMID:
20703102
9.

Postoperative prognosis prediction of pancreatic cancer with seven microRNAs.

Lee KH, Lee JK, Choi DW, Do IG, Sohn I, Jang KT, Jung SH, Heo JS, Choi SH, Lee KT.

Pancreas. 2015 Jul;44(5):764-8. doi: 10.1097/MPA.0000000000000346.

PMID:
25906450
10.

Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.

Patnaik SK, Kannisto E, Knudsen S, Yendamuri S.

Cancer Res. 2010 Jan 1;70(1):36-45. doi: 10.1158/0008-5472.CAN-09-3153. Epub 2009 Dec 22.

11.

Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up.

Markou A, Yousef GM, Stathopoulos E, Georgoulias V, Lianidou E.

Clin Chem. 2014 Jan;60(1):197-205. doi: 10.1373/clinchem.2013.210542. Epub 2013 Oct 16.

12.

MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation.

Yu J, Ohuchida K, Mizumoto K, Sato N, Kayashima T, Fujita H, Nakata K, Tanaka M.

Mol Cancer. 2010 Jun 28;9:169. doi: 10.1186/1476-4598-9-169.

13.

Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.

Drebber U, Lay M, Wedemeyer I, Vallböhmer D, Bollschweiler E, Brabender J, Mönig SP, Hölscher AH, Dienes HP, Odenthal M.

Int J Oncol. 2011 Aug;39(2):409-15. doi: 10.3892/ijo.2011.1036. Epub 2011 May 10.

PMID:
21567082
14.

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.

Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, Lee HS, Lee JS.

J Thorac Cardiovasc Surg. 2012 Oct;144(4):794-807. doi: 10.1016/j.jtcvs.2012.06.030. Epub 2012 Jul 18.

15.

Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma.

Kim BH, Hong SW, Kim A, Choi SH, Yoon SO.

J Surg Oncol. 2013 Apr;107(5):505-10. doi: 10.1002/jso.23271. Epub 2012 Sep 20.

PMID:
22996433
16.

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.

Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25.

PMID:
20363096
17.

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.

Qiu S, Lin S, Hu D, Feng Y, Tan Y, Peng Y.

J Transl Med. 2013 Jan 9;11:10. doi: 10.1186/1479-5876-11-10.

18.

Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection.

Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui J, Liu Y, Gao Z, Li J, Shen L, Lu Y.

Ann Oncol. 2011 Oct;22(10):2257-66. doi: 10.1093/annonc/mdq758. Epub 2011 Feb 22.

19.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
20.

Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.

Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H.

Mod Pathol. 2012 Jan;25(1):112-21. doi: 10.1038/modpathol.2011.142. Epub 2011 Oct 7.

Items per page

Supplemental Content

Write to the Help Desk